HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS

Francesco D'Alo', Federica Sora', Patrizia Chiusolo, Luca Laurenti, Luigi Maria Larocca, Simona Sica, Stefan Hohaus, Maria Chiara Tisi, Elena Maiolo, Silvia Bellesi, Eleonora Alma, Marika Picardi

Risultato della ricerca: Contributo in rivistaContributo a convegnopeer review

Fingerprint Entra nei temi di ricerca di 'HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS'. Insieme formano una fingerprint unica.

Medicine & Life Sciences